Ventilator Associated Pneumonia (Vap) - Therapeutics Market Report

China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：232
  • REPORT CODE：GMM1788470
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Ventilator Associated Pneumonia (Vap) - Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • Aridis Pharmaceuticals

    • Adenium Biotech ApS

    • Tetraphase Pharmaceuticals

    • MedImmune

    • Nabriva Therapeutics

    • Dong-A Socio

    • Serendex Pharmaceuticals

    • Cardeas Pharma

    • AstraZeneca

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Overview 2018-2029

    • 1.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Development Overview

    • 1.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Development History

    • 1.3 China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis by Region

      • 1.6.1 North China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Ventilator Associated Pneumonia (Vap) - Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Development

    Chapter 3 Ventilator Associated Pneumonia (Vap) - TherapeuticsIndustry Chain Analysis

    • 3.1 Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Chain

    • 3.2 Ventilator Associated Pneumonia (Vap) - Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Ventilator Associated Pneumonia (Vap) - Therapeutics Market

    • 3.3 Ventilator Associated Pneumonia (Vap) - Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Ventilator Associated Pneumonia (Vap) - Therapeutics Market

    Chapter 4 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 4.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Ventilator Associated Pneumonia (Vap) - Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate of Type 1

      • 4.5.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate of Type 2

      • 4.5.3 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate of Type 3

    Chapter 5 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Ventilator Associated Pneumonia (Vap) - Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate of Application 1

      • 5.5.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate of Application 2

      • 5.5.3 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate of Application 3

    Chapter 6 China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Region

    • 6.1 China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 7.1 North China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 7.2 North China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 8 Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 8.1 Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 8.2 Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 9 South China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 9.1 South China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 9.2 South China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 10 East China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 10.1 East China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 10.2 East China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 11 Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 11.1 Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 11.2 Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 12 Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 12.1 Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 12.2 Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 13 Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Analysis

    • 13.1 Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Type

    • 13.2 Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Aridis Pharmaceuticals

        • 14.2.1 Aridis Pharmaceuticals Company Profile

        • 14.2.2 Aridis Pharmaceuticals Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Adenium Biotech ApS

        • 14.3.1 Adenium Biotech ApS Company Profile

        • 14.3.2 Adenium Biotech ApS Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Tetraphase Pharmaceuticals

        • 14.4.1 Tetraphase Pharmaceuticals Company Profile

        • 14.4.2 Tetraphase Pharmaceuticals Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 MedImmune

        • 14.5.1 MedImmune Company Profile

        • 14.5.2 MedImmune Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Nabriva Therapeutics

        • 14.6.1 Nabriva Therapeutics Company Profile

        • 14.6.2 Nabriva Therapeutics Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Dong-A Socio

        • 14.7.1 Dong-A Socio Company Profile

        • 14.7.2 Dong-A Socio Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Serendex Pharmaceuticals

        • 14.8.1 Serendex Pharmaceuticals Company Profile

        • 14.8.2 Serendex Pharmaceuticals Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Cardeas Pharma

        • 14.9.1 Cardeas Pharma Company Profile

        • 14.9.2 Cardeas Pharma Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 AstraZeneca

        • 14.10.1 AstraZeneca Company Profile

        • 14.10.2 AstraZeneca Ventilator Associated Pneumonia (Vap) - Therapeutics Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Research Conclusions

    • 15.2 Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Market Size (2018-2029)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Ventilator Associated Pneumonia (Vap) - Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Share by Type in 2018

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Share by Type in 2023

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Share by Application in 2018

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Share by Application in 2023

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Value by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Value Share by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Value by Region (2018-2023)

    • Table China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table North China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table South China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table East China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Ventilator Associated Pneumonia (Vap) - Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Aridis Pharmaceuticals Company Profile

    • Table Aridis Pharmaceuticals Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Adenium Biotech ApS Company Profile

    • Table Adenium Biotech ApS Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Tetraphase Pharmaceuticals Company Profile

    • Table Tetraphase Pharmaceuticals Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table MedImmune Company Profile

    • Table MedImmune Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Nabriva Therapeutics Company Profile

    • Table Nabriva Therapeutics Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Dong-A Socio Company Profile

    • Table Dong-A Socio Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Serendex Pharmaceuticals Company Profile

    • Table Serendex Pharmaceuticals Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Cardeas Pharma Company Profile

    • Table Cardeas Pharma Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Ventilator Associated Pneumonia (Vap) - Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US